HUMAPHARM: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HUMAPHARM
Largest movements
- Receivables within one year +€105,108
up €105,108 (+78.5%), from €133,901 to €239,009
of which Trade receivables: +€102,636
- Tangible fixed assets -€59,008
down €59,008 (-13.5%), from €437,423 to €378,416
of which Land and buildings: -€57,329
- Cash -€45,585
down €45,585 (-11.5%), from €395,025 to €349,440
mainly Contributions, distributions and other (-€135,000) and Receivables within one year (-€105,108)
- Trade debts +€114,679
up €114,679 (+66.3%), from €172,993 to €287,673
- Other debts -€63,260
down €63,260 (-12.4%), from €510,293 to €447,032
- Profit (loss) carried forward -€17,711
down €17,711 (-15.5%), from €113,935 to €96,224
- Gross operating margin +€11,220
up €11,220 (+2.8%), from €396,460 to €407,681
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,272,835 | €1,282,596 | +€9,762 | +0.8% |
| Fixed assets | 21/28 | €437,423 | €378,416 | -€59,008 | -13.5% |
| Tangible fixed assets | 22/27 | €437,423 | €378,416 | -€59,008 | -13.5% |
| Land and buildings | 22 | €399,234 | €341,904 | -€57,329 | -14.4% |
| Plant, machinery and equipment | 23 | €22,332 | €21,473 | -€859 | -3.8% |
| Furniture and vehicles | 24 | €15,858 | €15,038 | -€820 | -5.2% |
| Current assets | 29/58 | €835,411 | €904,181 | +€68,769 | +8.2% |
| Stocks and contracts in progress | 3 | €306,485 | €315,122 | +€8,637 | +2.8% |
| Stocks | 30/36 | €306,485 | €315,122 | +€8,637 | +2.8% |
| Amounts receivable within one year | 40/41 | €133,901 | €239,009 | +€105,108 | +78.5% |
| Trade receivables | 40 | €133,883 | €236,519 | +€102,636 | +76.7% |
| Other amounts receivable | 41 | €18 | €2,490 | +€2,472 | +13733.9% |
| Cash at bank and in hand | 54/58 | €395,025 | €349,440 | -€45,585 | -11.5% |
| Deferred charges and accrued income | 490/1 | €0 | €609 | +€609 | |
| Total equity and liabilities | 10/49 | €1,272,835 | €1,282,596 | +€9,762 | +0.8% |
| Equity | 10/15 | €270,727 | €253,016 | -€17,711 | -6.5% |
| Contributions | 10/11 | €142,539 | €142,539 | = | 0.0% |
| Capital | 10 | €142,539 | €142,539 | = | 0.0% |
| Issued capital | 100 | €142,539 | €142,539 | = | 0.0% |
| Reserves | 13 | €14,254 | €14,254 | = | 0.0% |
| Non-distributable reserves | 130/1 | €14,254 | €14,254 | = | 0.0% |
| Legal reserve | 130 | €14,254 | €14,254 | = | 0.0% |
| Profit (loss) carried forward | 14 | €113,935 | €96,224 | -€17,711 | -15.5% |
| Amounts payable | 17/49 | €1,002,107 | €1,029,580 | +€27,472 | +2.7% |
| Amounts payable after more than one year | 17 | €265,552 | €253,537 | -€12,015 | -4.5% |
| Financial debts | 170/4 | €265,552 | €253,537 | -€12,015 | -4.5% |
| Amounts payable within one year | 42/48 | €730,056 | €769,543 | +€39,487 | +5.4% |
| Current portion of amounts payable after more than one year | 42 | €17,667 | €12,015 | -€5,652 | -32.0% |
| Trade debts | 44 | €172,993 | €287,673 | +€114,679 | +66.3% |
| Suppliers | 440/4 | €172,993 | €287,673 | +€114,679 | +66.3% |
| Taxes, remuneration and social security | 45 | €29,103 | €22,823 | -€6,280 | -21.6% |
| Taxes | 450/3 | €7,348 | €839 | -€6,509 | -88.6% |
| Remuneration and social security | 454/9 | €21,755 | €21,984 | +€229 | +1.1% |
| Other amounts payable | 47/48 | €510,293 | €447,032 | -€63,260 | -12.4% |
| Accrued charges and deferred income | 492/3 | €6,500 | €6,500 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €156,008 | €157,993 | +€1,985 | +1.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €72,969 | €75,361 | +€2,392 | +3.3% |
| Other operating charges | 640/8 | €4,675 | €5,242 | +€568 | +12.1% |
| Gross operating margin | 9900 | €396,460 | €407,681 | +€11,220 | +2.8% |
| Operating profit (loss) | 9901 | €162,809 | €169,084 | +€6,275 | +3.9% |
| Financial income | 75/76B | €536 | €830 | +€294 | +54.8% |
| Recurring financial income | 75 | €536 | €830 | +€294 | +54.8% |
| Financial charges | 65/66B | €12,070 | €11,538 | -€531 | -4.4% |
| Recurring financial charges | 65 | €12,070 | €11,538 | -€531 | -4.4% |
| Profit (loss) for the period before taxes | 9903 | €151,276 | €158,376 | +€7,100 | +4.7% |
| Income taxes | 67/77 | €38,817 | €41,087 | +€2,270 | +5.8% |
| Profit (loss) for the period | 9904 | €112,459 | €117,289 | +€4,830 | +4.3% |
| Profit (loss) for the period to be appropriated | 9905 | €112,459 | €117,289 | +€4,830 | +4.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.